Abstract:This work defines a novel tumor‐suppressive E3 ubiquitin ligase RING finger protein 182 (RNF182) which induces ubiquitination and degradation of p65 and consequently suppresses the transcription of programmed death ligand 1, therefore, alleviating immunosuppression and cancer development. These findings may offer new ideas that RNF182 may be used as a strategy to help reduce immune escape and limit tumor growth in lung adenocarcinoma. Background The RING finger (RNF) proteins are a large group of ubiquitin ligases whose aberrant expression is often associated with disease progression. This study examines the function of RNF protein 182 (RNF182) in lung adenocarcinoma (LUAD) cells and its impact on p65 and programmed death ligand 1 (PDL1) regulation. Methods Expression of RNF182, p65, and PDL1 in LUAD tissues and cells was measured using immunohistochemistry, reverse transcription quantitative polymerase chain reaction (RT‐qPCR), and/or western blot (WB) assays. LUAD cells were induced to overexpress RNF182 and p65, followed by cell counting kit‐8, colony formation, Transwell, and flow cytometry assays to evaluate the cells' malignant phenotype. Coimmunoprecipitation and WB assays were used to verify RNF182's effect on p65 ubiquitination. Chromatin immunoprecipitation‐qPCR and luciferase assays were used to analyze p65's transcriptional regulation of PDL1. Coculture of LUAD with CD8+ cytotoxic T cells was performed to detect lactate dehydrogenase release and interferon‐γ and interleukin‐2 concentrations. LUAD cells were implanted in mice to analyze tumorigenicity. Results RNF182 was poorly expressed, while p65 and PDL1 were highly expressed in LUAD tissues and cells. RNF182 overexpression suppressed the malignant properties of LUAD cells, and it promoted p65 ubiquitination and protein degradation. p65 activated PDL1 transcription. Overexpression of RNF182 suppressed the PDL1 expression, increased the cytotoxicity in LUAD cells cocultured with CD8+ T cells, and suppressed the tumorigenesis of cancer cells in vivo. However, these tumor‐suppressive effects of RNF182 on LUAD cells were blocked by p65 restoration. Conclusion This research demonstrates that RNF182 induces p65 ubiquitination to suppress PDL1 transcription and immunosuppression in LUAD.

RNF115-mediated ubiquitination of p53 regulates lung adenocarcinoma proliferation

RNF115 promotes lung adenocarcinoma through Wnt/β-catenin pathway activation by mediating APC ubiquitination

E3 ubiquitin ligase PJA1 regulates lung adenocarcinoma apoptosis and invasion through promoting FOXR2 degradation

The tumor suppressor p53 regulates autophagosomal and lysosomal biogenesis in lung cancer cells by targeting transcription factor EB.

RNF8 Promotes Lung Cancer Tumorigenesis and Chemoresistance by Regulating AKT

RNF8-mediated regulation of Akt promotes lung cancer cell survival and resistance to DNA damage

Long Noncoding RNA LCAT1 Functions As a Cerna to Regulate RAC1 Function by Sponging Mir-4715-5p in Lung Cancer

Novel Evidence for Retinoic Acid-Induced G (Rig-G) As a Tumor Suppressor by Activating P53 Signaling Pathway in Lung Cancer.

LUCAT1 Activates the Malignant Phenotypes of Lung Cancer Cells Via Regulating P53 Ubiquitination.

LncRNA H19 Promotes Lung Adenocarcinoma Progression Via Binding to Mutant P53 R175H

LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex‐mediated changes in chromatin structure in lung adenocarcinoma

FAM111B, a direct target of p53, promotes the malignant process of lung adenocarcinoma.

RNF182 induces p65 ubiquitination to affect PDL1 transcription and suppress immune evasion in lung adenocarcinoma

PHD-finger Domain Protein 5A Functions As a Novel Oncoprotein in Lung Adenocarcinoma

Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation

USP53 Promotes Apoptosis and Inhibits Glycolysis in Lung Adenocarcinoma Through FKBP51‐AKT1 Signaling

Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187

Ring finger protein 19A is overexpressed in non-small cell lung cancer and mediates p53 ubiquitin-degradation to promote cancer growth

CDK16 Phosphorylates and Degrades P53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer.

p53 governs an AT1 differentiation programme in lung cancer suppression

Retraction Note: LINC00355 Induces Gastric Cancer Proliferation and Invasion Through Promoting Ubiquitination of P53